共 40 条
- [31] Response to Letter to the Editor Regarding: "Adverse Events and Complications Associated With Intrathecal Drug Delivery Systems: Insights From the Manufacturer and User Facility Device Experience (MAUDE) Database"NEUROMODULATION, 2021, 24 (04): : 798 - 798Goel, VasudhaShankar, Hariharan
- [32] Re: Complications after Minimally Invasive Sacrocolpopexy with and without Concomitant Incontinence Surgery: A National Surgical Quality Improvement Program (NSQIP) Database Study Editorial CommentJOURNAL OF UROLOGY, 2019, 201 (02): : 233 - 233Wein, Alan J.
- [33] Editorial Comment: Medical Therapy Versus Surgery and Minimally invasive Surgical Therapies for Lower Urinary Tract Symptoms and Benign Prostatic Hyperpasia: What Makes Better Economic Sense?JOURNAL OF UROLOGY, 2009, 181 (01): : 242 - 243Kaplan, Steven A.
- [34] Re: 180W-LBO GreenLight XPS Laser Vaporization for Benign Prostatic Hyperplasia: Our Experience with Current Markers of Surgical Proficiency for Durable and Reproducible Outcomes Editorial CommentJOURNAL OF UROLOGY, 2019, 201 (02): : 203 - 203Kaplan, Steven A.
- [35] Re: Temporary Implantable Nitinol Device (TIND): A Novel, Minimally Invasive Treatment for Relief of Lower Urinary Tract Symptoms (LUTS) Related to Benign Prostatic Hyperplasia (BPH): Feasibility, Safety and Functional Results at 1 Year of Follow-up Editorial CommentJOURNAL OF UROLOGY, 2016, 195 (06): : 1837 - 1837Kaplan, Steven A.
- [36] Editorial Comment on: Device-Related Adverse Events During Percutaneous Nephrolithotomy: Review of the Manufacturer and User Facility Device Experience Database by Patel et al. (From: Patel NH, Schulman AA, Bloom JB, et al. J Endourol 2017;31:1007-1011)JOURNAL OF ENDOUROLOGY, 2018, 32 (01) : 73 - 74Andonian, Sero
- [37] A Response to "Major Complications Associated With Xenograft Biologic Mesh Implantation in Abdominal Wall Reconstruction"(Harth KC, Rosen MJ. Surg Innov. 2009;16:324-329) and Discussion of the MAUDE (Manufacturer and User Facility Device Experience) Database, FDA Regulation of Biologic Implants, and Evidence-Based Medicine ResponseSURGICAL INNOVATION, 2010, 17 (03) : 276 - 276Harth, Karem C.Rosen, Michael J.
- [38] A Response to "Major Complications Associated With Xenograft Biologic Mesh Implantation in Abdominal Wall Reconstruction"(Harth KC, Rosen MJ. Surg Innov. 2009;16:324-329) and Discussion of the MAUDE (Manufacturer and User Facility Device Experience) Database, FDA Regulation of Biologic Implants, and Evidence-Based MedicineSURGICAL INNOVATION, 2010, 17 (03) : 273 - 275Segan, Ross David
- [39] Re: Aminsharifi et al., Major Complications and Adverse Events Related to the Injection of the SpaceOAR Hydrogel System Before Radiotherapy for Prostate Cancer: Review of the Manufacturer and User Facility Device Experience Database (From: Aminsharifi A, Kotamarti S, Silver D, et al., J Endourol 2019;33:868-871; DOI: 10.1089/end.2019.0431)JOURNAL OF ENDOUROLOGY, 2020, 34 (02) : 240 - 241Babayan, Richard K.Steinberg, Michael L.Miller, Larry E.
- [40] Response to: Babayan, Steinberg, and Miller RE: Aminsharifi et al., Major Complications and Adverse Events Related to the Injection of the SpaceOAR Hydrogel System Before Radiotherapy for Prostate Cancer: Review of the Manufacturer and User Facility Device Experience Database (From: Babayan RK, Steinberg ML, and Miller LE, J Endourol 2020;34:240-241; DOI: 10.1089/end.2019.0742)JOURNAL OF ENDOUROLOGY, 2020, 34 (02) : 242 - 242Aminsharifi, AlirezaSilver, DavidSchulman, Ariel